| Description: |
Scientists now have a high-resolution view of exactly how the experimental therapy ZMapp targets Ebola virus. This new study is also the first to show how an antibody in the ZMapp "drug cocktail" targets a second Ebola virus protein, called sGP, whose vulnerable spots had previously been unknown. [Source: The Scripps Research Institute]
|
 |
